Lung and skin tissues and sera from patients with severe COVID-19 have shown increased complement activation and massive generation of C5a, C5b-C9, and C5aR1 in blood and pulmonary myeloid cells [209]. The gene discussed is C5AR1; the disease is COVID-19.